are summarized in Table I . In five cases, the women were referred to our center for the second pregnancy, in case 3 for the third pregnancy, and in case 6, for the fourth pregnancy. In the two other cases, there was no previous history of NAIT, but the women were considered at risk because they were fetal platelets was elevated (Table  2) . Therapy during pregnancy, before 35 weeks of gestation, was attempted for case 3. The mother was treated with IV
RESULTS
IgG 0.4 g/kg/day for 5 days. This treatment apparently had
In four of the seven cases with a sibling history of NAIT no effect on fetal platelet count, but repeated fetal tranfu- (Table   2 , cases 3, 4, 6, and 7), FBS was performed at 20 to 22 sions were done until fetal maturity allowed delivery. This weeks of gestation.
Severe thrombocytopenia was detected in case emphasized the short duration (not more than 1 week) three cases (cases 3, 4, and 6). In case 7, the platelet count of the efficacy of platelet transfusion. 
